Poster Open Access

Potential of Mesoporous Silica Nanoparticles for Applications in Targeted Treatment of Cancer

Minja Mladenović; Mirjana Mundžić; Aleksandra Pavlović; Nikola Knežević

Background: Mesoporous silica nanoparticles (MSN) are being vastly demonstrated in the literature as efficient nanocarriers for cancer therapeutics. Their high surface area (ca. 1000 m2/g), well-structured porosity, versatile possibilities for obtaining nanocarriers of different morphologies, pore diameters and surface characteristics, allow construction of different nanosystems for efficient cancer targeting. Methods: In this study, the potential of mesoporous silica nanoparticles for applications in targeted treatment of cancer is presented. Results: Our team focuses on construction and surface functionalization of MSN with different moieties for active cancer-targeting. The drug release process can be also controlled through different externally applicable stimuli (eg. light irradiation, magnetic field), or upon exposure to intratumoral conditions such as weakly acidic environment, the elevated concentration of glutathione or other cancer biomarkers. In addition, MSN can be decorated with specific moieties to enable imaging of cancer (eg. magnetic resonance imaging (MRI)), which would enable simultaneous cancer therapy and diagnostics (theranostics). Conclusions: Mesoporous silica nanoparticles have substantial potentials for enhancing the efficacy and precision of cancer treatment.

Acknowledgments: The authors acknowledge financial support of the Science Fund of the Republic of Serbia (PROMIS Grant No. 6060755) and the European Union's Horizon 2020 research and innovation programme (Grant agreement No. 952259).
Files (1.2 MB)
Name Size
Poster_SDIR5 2021 final.pdf
md5:3689dcb2512c29ccd06b9c0895302720 		1.2 MB Download
57
22
views
downloads
All versions This version
Views 5757
Downloads 2222
Data volume 26.8 MB26.8 MB
Unique views 5151
Unique downloads 2222
More info on how stats are collected.
Indexed in
Publication date:
December 3, 2021
DOI:
10.5281/zenodo.5769294

Zenodo DOI Badge

DOI 

10.5281/zenodo.5769294

Markdown 

[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.5769294.svg)](https://doi.org/10.5281/zenodo.5769294)

reStructedText 

.. image:: https://zenodo.org/badge/DOI/10.5281/zenodo.5769294.svg
   :target: https://doi.org/10.5281/zenodo.5769294

HTML 

<a href="https://doi.org/10.5281/zenodo.5769294"><img src="https://zenodo.org/badge/DOI/10.5281/zenodo.5769294.svg" alt="DOI"></a>

Image URL 

https://zenodo.org/badge/DOI/10.5281/zenodo.5769294.svg

Target URL 

https://doi.org/10.5281/zenodo.5769294

Keyword(s):
Mesoporous silica nanoparticles (MSNs) nanocarriers targeted anti-cancer drug delivery
Grants:
European Commission:
  • NANOFACTS - Networking Activities for Nanotechnology-Facilitated Cancer Theranostics (952259)
Communities:
License (for files):
Creative Commons Attribution 4.0 International

Versions

Version 1 10.5281/zenodo.5769294 Dec 3, 2021
Cite all versions? You can cite all versions by using the DOI 10.5281/zenodo.5769293. This DOI represents all versions, and will always resolve to the latest one. Read more.

Share

Cite as

Export